AustinPx Live Episode 3: From Molecule to Milestone: Fast-Track Formulation

Watch the third session in our AustinPx Live series! Chief Scientific Officer, Dave Miller, Ph.D., will share how AustinPx approaches conventional formulation to accelerate First-in-Human studies without sacrificing scientific rigor. He’ll highlight how our expertise in powder-in-capsule dosing, phase-appropriate analytical support, and early manufacturability considerations helps sponsors navigate tight timelines and reach the clinic with confidence. This 30-minute session includes a 20-minute presentation followed by live Q&A.